Mridusmita Saikia is an interdisciplinary scientist with expertise in biochemistry, molecular biology, and genomics. She completed her Ph.D. at the University of Chicago, where she developed quantitative high throughput biochemical assays to analyze RNA modification levels in biological systems. Her work was supported by a fellowship from the Burroughs-Wellcome Trust. Following her Ph.D., she conducted postdoctoral research at Case Western Reserve University and Cornell University, focusing on non-coding RNAs and their role in gene expression control. Currently, Dr. Saikia is using single-cell RNA sequencing technology to study human immune cell function and human pancreatic beta cell pathology related to diabetes. She joined the Meinig School of Biomedical Engineering at Cornell University in July 2020 and teaches courses in the field of Cellular Molecular Engineering, aiming to help students understand fundamental concepts in biomedical engineering and their applications to improve bodily functions.